Feature | Clinical Decision Support | January 18, 2018

National Decision Support Company Acquired by Change Healthcare

Purchase will help bring clinical intelligence to the point of care, meet healthcare reform guidelines

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader in cloud-based clinical decision support (CDS) software that delivers medical guidelines to the point of care in electronic medical record (EMR) systems. The addition of NDSC accelerates the efforts of Change Healthcare to leverage evidence-based clinical information and next-generation technologies to help reduce healthcare costs and ensure appropriate care.

"We are singularly focused on helping customers address the big challenges in healthcare—achieving better outcomes, reducing costs, and creating an interconnected healthcare ecosystem. With NDSC, we've added strategic capabilities to accelerate our product roadmap and increase the value we provide to healthcare stakeholders," said Neil de Crescenzo, president and chief executive officer (CEO), Change Healthcare. "NDSC puts clinical intelligence in the hands of physicians and other clinicians as they are delivering care. With ready access to medical guidelines, clinicians can make decisions that lead to better patient outcomes, improve efficiency, and optimize care paths based on world-class clinical expertise."

NDSC's flagship offering, CareSelect Imaging, delivers evidence-based guidelines for medical imaging through an exclusive digital distribution license with the American College of Radiology (ACR). This relationship also puts the company in a position to help customers meet federal healthcare reform mandates requiring that clinicians consult appropriate use criteria (AUC) for imaging. 

NDSC's current portfolio also includes CareSelect Choosing Wisely, founded on the American Board of Internal Medicine's Choosing Wisely Initiative, and CareSelect Lab, based on a partnership with the Mayo Clinic. With a rapidly growing customer base of more than 500 provider organizations, NDSC is a proven technology platform for the delivery of guidance at the point of order.

NDSC and the Change Healthcare InterQual team have used the NDSC platform to deliver industry leading clinical criteria to the point of care, leveraging real-time access to clinical data. The goal of this relationship is to streamline utilization management and authorization processes, which today are labor-intensive, redundant, and expensive.

"We have forged a strong and complementary working relationship across our teams with a special, rarely attained energy," said Michael Mardini, CEO, NDSC, who will continue leading the NDSC team within Change Healthcare as part of the company's decision support portfolio. "We share a vision and passion for improving care delivery through innovative technology and common-sense process improvements. This strategic and cultural fit will accelerate the success of our combined organizations, and it expands our ability to deliver solutions that improve patient care and decrease cost across the payer and provider ecosystem."

The NDSC team will continue to operate from its offices in Madison, Wis. The NDSC acquisition also accelerates the expansion of Change Healthcare's operations in Madison through the planned addition of other company operations there.

Change Healthcare leverages software, analytics, network solutions and technology-enabled services to enable better patient care through EMRs. Change acquired McKesson’s information technology division, including cardiology and radiology IT solutions, in 2017.  

For more information: www.changehealthcare.com

Related Content

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China) #COVID2019 #COVID19 #coronavirus #2019nCoV

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China)

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — The first in a series of medical imaging studies on novel coronavirus (COVID-19) was published on
AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV

AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COV
 LucidHealth, a physician-owned and led radiology company, announced today that it is using an AI-powered diagnostic aid from leading AI vendor Aidoc to help prioritize and expedite treatment to patients with critical, life-threatening conditions
News | Artificial Intelligence | February 28, 2020
February 28, 2020 — LucidHealth, a physician-owned and led r
Qure.ai, a leading healthcare AI startup
News | Artificial Intelligence | February 27, 2020
February 27, 2020 — Qure.ai, a leading healthcare AI startup has ann
Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine

Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine. Photo credit: Tech Parks Arizona

News | Ultrasound Imaging | February 27, 2020
February 27, 2020 — Emagine Solutions Technology, an award-winnin
In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19) #COVID19 #COVID-2019 #2019nCoV #COVID-19

Chest CT images of a 29-year-old man with fever for 6 days. RT-PCR assay for the SARS-CoV-2 using a swab sample was performed on Feb. 5, 2020, with a positive result. (A column) Normal chest CT with axial and coronal planes was obtained at the onset. (B column) Chest CT with axial and coronal planes shows minimal ground-glass opacities in the bilateral lower lung lobes (yellow arrows). (C column) Chest CT with axial and coronal planes shows increased ground-glass opacities (yellow arrowheads). (D column) Chest CT with axial and coronal planes shows the progression of pneumonia with mixed ground-glass opacities and linear opacities in the subpleural area. (E column) Chest CT with axial and coronal planes shows the absorption of both ground-glass opacities and organizing pneumonia. Image courtesy of Radiology

News | Computed Tomography (CT) | February 26, 2020 | Melinda Taschetta-Millane and Dave Fornell
February 26, 2020 — In a study of m
 over the course of a week and a half #coronavirus #COVID19 #COVID-2019 #2019nCoV

29-year old male with unknown exposure history, presenting with fever and cough, ultimately requiring intensive care unit admission. (a) Axial thin-section non-contrast CT scan shows diffuse bilateral confluent and patchy ground-glass (solid arrows) and consolidative (dashed arrows) pulmonary opacities. (b) The disease in the right middle and lower lobes has a striking peripheral distribution (arrow). Image courtesy of Radiology 

News | Computed Tomography (CT) | February 26, 2020
February 26, 2020 — Mount Sinai Health System physicians—the
Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV) #coronavirus #nCoV2019 #2019nCoV #COVID19

Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV). Three representative axial thin-section chest CT images show multifocal ground glass opacities without consolidation. Three-dimensional volume-rendered reconstruction shows the distribution of the ground-glass opacities (arrows). Image courtesy of the Radiological Society of North America (RSNA)

News | Radiology Imaging | February 25, 2020
February 24, 2020 — The U.S.